CSIMarket
 
Steris Plc  (STE31)
Other Ticker:  
 
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 100
 Employees 14,000
 Revenues (TTM) (Millions $) 4,784
 Net Income (TTM) (Millions $) -29
 Cash Flow (TTM) (Millions $) -100
 Capital Exp. (TTM) (Millions $) 364

Steris Plc
Steris Plc is a medical device and pharmaceutical company that is involved in the development, manufacturing, and marketing of products and solutions for the healthcare industry.
The company offers a wide range of products encompassing sterilization equipment, surgical tables, lighting systems, and infection prevention solutions.
The company was established in 1985 and has its headquarters located in Dublin, Ireland.
The company operates through three segments, namely Healthcare Products, Healthcare Specialty Services, and Life Sciences.
Healthcare Products segment offers infection prevention and procedural products, capital equipment, and related biopharmaceutical services, whereas Healthcare Specialty Services segment provides a range of support services, including equipment, maintenance, and inspections, for healthcare facilities.
Life Sciences segment provides reagents, cleaning chemistries, and validation services primarily for life science customers and pharmaceutical manufacturers.
Steris Plc has a global presence with operations in North America, Europe, Asia Pacific, and Latin America.
The company serves a wide range of customers, including hospitals, medical device manufacturers, and pharmaceutical companies.
Today, Steris is among the largest providers of medical sterility products worldwide, with a leadership position in the market for endoscope reprocessing equipment.
In addition to its strong commercial focus, Steris Plc is also committed to sustainability and social responsibility.
The company has adopted a number of initiatives that aim to minimize the environmental impact of its operations, reduce waste and eliminate toxins.
Steris also actively supports community projects and charitable organizations that aim to improve access to healthcare and education.


   Company Address: 70 Sir John Rogerson s Quay, Dublin 2, 0
   Company Phone Number: 1 232 2000   Stock Exchange / Ticker: NYSE STE31
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Yubo International Biotech Limited

The Medical Equipment and Supplies company declared devastating revenue slide, in the fourth quarter of 2023 earnings season

For the financial fourth quarter of 2023 company reached 0 of $0.00 per share compare to $0.00 a year prior and from $0.00 per share from the prior quarter. The revenue fell sharply by -72.759 % to $0.02 million from $0.07 million in the corresponding quarter a year prior and sequentially Revenue Tumbled by -95.771 % from $0.43 million.

Sep Acquisition Corp

Among many businesses, the SEPA disclosed as well the fourth quarter of 2023 numbers

The Medical Equipment and Supplies industry consultants start to digest the fourth quarter of 2023 results. Today those consultants observe operating loss of $-1.403343 million, from the Sep Acquisition Corp , which hasn't mentioned any revenue still, for the respective October to December 31 2023 quarter.

Digital Health Acquisition Corp

In the financial fourth quarter of 2023 operating shortfall illustrated improvement to $-1.200265 million, at the Medical Equipment and Supplies company

The investors haven't assumed some moderations at the top-line during the the October to December 31 2023 reporting season at the company. But, shareholders monitor DHACs' operating shortfall that was at $-0.92566 million, in the same period.

Trisalus Life Sciences Inc

Trisalus Life Sciences Inc released Revenue of $12.713 million, in the most recent fiscal period

the Medical Equipment and Supplies company revealed $12.713 million, in Revenue in the most recent fiscal period.

Infusystem Holdings Inc

Excellent result by the company during the financial time-frame ending December 31 2023

company announced net profit per share of $0.00 and Revenue of $31.91 million in its financial time-frame ending December 31 2023, INFUs' reached break-even $0.00 per share, versus $0.00 eps, earned in fourth quarter of 2022, although INFU saw its Revenue rise by 10.201 % in the similar period. Infusystem Holdings Inc s' revenue advanced more compared to the the top-line at most of the Medical Equipment and Supplies sector contemporaries, in the fourth quarter of 2023 the most companies in Medical Equipment and Supplies industries reported an average revenue growth of 10.08% relative to the Q4 of 2022.






 

Steris Plc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com